Podcast: Navigating the New Rules of Healthcare Advertising

HIPAA Isn't Enough Anymore

For years, healthcare marketers used HIPAA as their north star for privacy compliance. If you weren't touching Protected Health Information (PHI), you were in the clear. That framework made sense when HIPAA was the only game in town.

But things have changed. Today, 21 states have passed comprehensive privacy laws that apply to healthcare advertising—even when HIPAA doesn't. These laws regulate health inferences, not just confirmed medical facts. They define "sensitive data" more broadly than HIPAA ever did. And they give consumers rights that HIPAA never contemplated.

The result? HIPAA compliance is necessary but no longer sufficient. Healthcare marketers need to think beyond covered entities and business associates. They need to understand how state privacy laws reshape the rules for audience targeting, even in contexts that fall outside HIPAA's scope entirely.

The State Privacy Law Patchwork

One of the biggest challenges healthcare marketers face isn't just that privacy laws exist—it's that every state does it differently. California's approach differs from Virginia's. Colorado has unique requirements. Washington State takes its own path.

Some states classify health data as "sensitive" and require explicit consent before it can be used for targeted advertising. Others create special rules around inferences about health conditions. Still others regulate data brokers in ways that fundamentally change how audience segments can be built and deployed.

During the podcast, we discussed how this patchwork creates operational complexity for national healthcare campaigns. You can't run a single strategy across all 50 states anymore. What works in Texas might violate the law in California. What's permissible in Florida might create liability in Colorado. Navigating this landscape requires both legal expertise and technical infrastructure that most audience vendors simply don't have.

Why Health Inferences Are the New Risk Frontier

Here's something most healthcare marketers miss: you don't need to know someone's actual health status to create legal exposure. Making an inference about someone's health can be just as risky—and in some cases, riskier—than using confirmed medical data.

State privacy laws increasingly treat health inferences as sensitive information. If you're building audience segments that predict or assume someone has a medical condition—even if you never had access to their medical records—you may be subject to the same restrictions that apply to actual health data.

This is why modeled audiences create such significant compliance exposure in healthcare. When an algorithm predicts that someone has diabetes, hypertension, or cancer based on their browsing behavior and demographic profile, that prediction is an inference. And under many state laws, that inference is regulated—regardless of whether the prediction is accurate.

During our conversation, I emphasized that the safest path forward isn't to make better predictions about individuals. It's to stop making individual-level health inferences altogether and build audiences using group-level patterns and contextual signals instead.

Building Privacy-Safe Audiences Without Sacrificing Performance

The fear among many healthcare marketers is that complying with privacy laws means giving up performance. If you can't use predictive models, if you can't make inferences about health status, if you can't target individuals based on their medical conditions—how do you reach the right people?

The answer is that you shift your approach from targeting individuals to understanding groups. Instead of asking "Who has this condition?" you ask "Where are people with this condition engaging?" You look at contextual signals—what content people consume, what searches they perform, what communities they participate in—rather than making person-level health predictions.

This isn't just about compliance. It's often more effective. Group-level targeting based on behavioral patterns and contextual relevance frequently outperforms inference-based models, especially for rare diseases and specialty conditions where predictive accuracy is inherently low.

At Blueprint Audiences, we've built our entire platform around this principle: you can reach the right audiences at scale without making guesses about anyone's health status. That's privacy-safe targeting that actually performs.

Consumer Rights Are Here—and They're Non-Negotiable

One of the most significant shifts happening right now is the emergence of consumer privacy rights in healthcare advertising. Under state privacy laws, consumers have the right to know what data is collected about them, the right to opt out of certain uses, and the right to delete their information entirely.

These aren't theoretical rights. They're enforceable. Attorneys general are actively investigating companies that fail to honor consumer requests. We've seen enforcement actions against health data vendors and publishers who couldn't demonstrate adequate systems for managing consumer rights.

For healthcare marketers, this creates a critical question: when you activate an audience segment from a third-party vendor, can that vendor honor consumer opt-outs? Can they provide transparency into how the segment was built? Can they demonstrate that they're honoring deletion requests? If the answer to any of these questions is "no," you're taking on significant regulatory risk.

The Future Is Privacy-First, Not Privacy-Second

For too long, privacy in healthcare advertising was treated as an afterthought. Marketers built their strategies first, then tried to make them compliant later. That approach doesn't work anymore.

The future of healthcare advertising is privacy-first. That means designing campaigns with privacy at the core from the start—not bolting it on at the end. It means choosing audience partners who build compliance into their data infrastructure, not vendors who promise to "handle compliance" with vague assurances.

It also means recognizing that privacy isn't just a legal obligation. It's a competitive advantage. Consumers increasingly expect brands—especially healthcare brands—to handle their information responsibly. The organizations that get ahead of privacy requirements, rather than reacting to them, will build stronger patient relationships and more sustainable marketing programs.

Key Takeaways from the Conversation

• HIPAA isn't enough — state privacy laws now regulate healthcare advertising even when HIPAA doesn't apply
• Health inferences are regulated — making predictions about someone's health creates the same compliance exposure as using confirmed health data
• 21 states, 21 different laws — the privacy law patchwork creates operational complexity for national campaigns
• Consumer rights are enforceable — opt-outs, access requests, and deletion rights aren't optional anymore
• Group-level targeting works — you can reach the right audiences without making individual-level health inferences
• Privacy-first wins — building compliance into your strategy from the start is more effective than retrofitting it later